GlassScriptPhysician profile
Carlie Stott
NPI 1235767435
$3,733.14
in general payments reported to CMS, 2019-2025
17 companies · $683 in 2025
The $683 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $356 · 2022: $674 · 2023: $1,233 · 2024: $787 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,702.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $919.88 | 2021-2025 | Erleada, Akeega, Rybrevant |
| Janssen Scientific Affairs, LLC | $525.54 | 2022-2025 | Akeega, Erleada, Balversa |
| Astrazeneca Pharmaceuticals LP | $396.94 | 2021-2025 | Datroway |
| E.R. Squibb & Sons, L.L.C. | $351.86 | 2021-2024 | Opdivo |
| Daiichi Sankyo INC. | $294.53 | 2023-2025 | Enhertu, Datroway |
| Amgen INC. | $286.36 | 2021-2024 | Blincyto, Kyprolis |
| Exelixis INC. | $246.87 | 2022-2023 | Cabometyx |
| Merck Sharp & Dohme LLC | $207.87 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $126.04 | 2023 | Pemazyre |
| Tempus Ai, INC | $107.05 | 2024 | |
| Immunocore Limited | $79.86 | 2024 | Kimmtrak |
| Bayer Healthcare Pharmaceuticals INC. | $54.26 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $51.52 | 2024 | |
| Astellas Pharma US INC | $22.99 | 2023 | Xtandi |
| Nuvation Bio INC. | $21.33 | 2025 | Ibtrozi |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $21.01 | 2025 | |
| Seagen INC. | $19.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlie Stott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.